CL-197

• CAT Number: I042647
• CAS Number: 1030595-07-3
• Molecular Formula: C12H11F2N5O3
• Molecular Weight: 311.24
• Purity: ≥95%
• Synonyms: (2R,4R,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-ethynyl-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
• IUPAC Name: (2R,3R,4S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-ethynyl-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
• InChI: InChI=1S/C12H11F2N5O3/c1-2-12(3-20)7(21)5(13)10(22-12)19-4-16-6-8(15)17-11(14)18-9(6)19/h1,4-5,7,10,20-21H,3H2,(H2,15,17,18)/t5-,7-,10+,12+/m0/s1
• InChIKey: CKOSILJGTGQALV-MPOXBOEASA-N
• SMILES: C#C[C@]1([C@H]([C@@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)F)N)F)O)CO

CL-197（Cat No.:I042647）is an experimental small molecule compound being investigated for its potential therapeutic applications in treating various types of cancer. It functions as a selective inhibitor of specific signaling pathways that regulate tumor growth, survival, and metastasis. By targeting key molecules involved in cancer cell proliferation and resistance to apoptosis, CL-197 aims to suppress tumor growth and enhance the effectiveness of other cancer therapies. Ongoing research focuses on evaluating its safety, pharmacokinetics, and efficacy in preclinical and clinical trials, particularly for cancers that are resistant to conventional treatments.